Augmented Serum Amyloid A1/2 Mediated by TNF-induced NF-kB in Human Serous Ovarian Epithelial Tumors
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Tumor necrosis factor-a (TNF) is well known to be involved in the immune system and ovarian inflammation. Ovarian cancer is an inflammation-related malignancy that lacks early screening strategies, resulting in late diagnosis followed by high mortality. Based on our previous data, TNF induced abundant serum amyloid A (SAA), an acute phase protein linked to inflammation, in ovarian granulosal cells. To date, the regulation and expression of SAA in ovarian cancer is not fully elucidated. Here, we investigated the relationship between TNF and SAA by comparing human normal ovarian tissues and serous ovarian tumors. We found that SAA1/2 was significantly expressed in tumor tissues, but no or trace expression levels in normal tissues. TNF was also significantly upregulated in ovarian tumor tissues compared to normal tissues. Moreover, TNF significantly increased SAA1/2 levels in human ovarian cancer cell lines, OVCAR-3 and SKOV-3, in a time-dependent manner. Since the SAA1 promoter contains two nuclear factor (NF)-kB sites, we examined whether TNF regulates SAA1 promoter activity. Deletion analysis revealed that the proximal NF-kB site (–95/–85) played a critical role in regulating TNF-induced SAA1 promoter activity. Within 2 h after intraperitoneal injection of lipopolysaccharide, a product known to stimulate release of TNF, SAA preferably localized to ovarian epithelial cells and the thecal-interstitial layers compared to granulosal cell layers. Based on Gene Expression Omnibus (GEO) database, SAA1/2 and TNF were dominantly expressed in advanced grade ovarian cancer. Taken together, the accumulation of SAA1/2 in ovarian cancer could be mediated by TNF-induced NF-kB activation.
Abstract
Tumor necrosis factor-a (TNF) is well known to be involved in the immune system and ovarian inflammation. Ovarian cancer is an inflammation-related malignancy that lacks early screening strategies, resulting in late diagnosis followed by high mortality. Based on our previous data, TNF induced abundant serum amyloid A (SAA), an acute phase protein linked to inflammation, in ovarian granulosal cells. To date, the regulation and expression of SAA in ovarian cancer is not fully elucidated. Here, we investigated the relationship between TNF and SAA by comparing human normal ovarian tissues and serous ovarian tumors. We found that SAA1/2 was significantly expressed in tumor tissues, but no or trace expression levels in normal tissues. TNF was also significantly upregulated in ovarian tumor tissues compared to normal tissues. Moreover, TNF significantly increased SAA1/2 levels in human ovarian cancer cell lines, OVCAR-3 and SKOV-3, in a time-dependent manner. Since the SAA1 promoter contains two nuclear factor (NF)-kB sites, we examined whether TNF regulates SAA1 promoter activity. Deletion analysis revealed that the proximal NF-kB site (–95/–85) played a critical role in regulating TNF-induced SAA1 promoter activity. Within 2 h after intraperitoneal injection of lipopolysaccharide, a product known to stimulate release of TNF, SAA preferably localized to ovarian epithelial cells and the thecal-interstitial layers compared to granulosal cell layers. Based on Gene Expression Omnibus (GEO) database, SAA1/2 and TNF were dominantly expressed in advanced grade ovarian cancer. Taken together, the accumulation of SAA1/2 in ovarian cancer could be mediated by TNF-induced NF-kB activation.
참고문헌 (21)
- Siegel, R. L., "Cancer statistics", CA Cancer J. Clin, 66, pp.7~30 (2016)
- Shih, I. M., "Ovarian tumorigenesis:a proposed model based on morphological and molecular genetic analysis", Am. J. Pathol, 164, pp.1511~1518 (2004)
- Kobel, M., "Ovarian carcinoma subtypes are different diseases: implications for biomarker studies", PLoS Med, 5, pp.e232~ (2008)
- Nowak, M., "Proinflammatory and immunosuppressive serum, ascites and cyst fluid cytokines in patients with early and advanced ovarian cancer and benign ovarian tumors", Neuro. Endocrinol. Lett, 31, pp.375~383 (2010)
- Clendenen, T. V., "Circulating inflammation markers and risk of epithelial ovarian cancer", Cancer Epidemiol. Biomarkers Prev, 20, pp.799~810 (2011)
- Son, D. S., "Characteristics of chemokine signatures elicited by EGF and TNF in ovarian cancer cells", J. Inflamm. (Lond), 10, pp.25~ (2013)
- Ignacio, R. M., "NF-kappaB-mediated CCL20 reigns dominantly in CXCR2-driven ovarian cancer progression", PLoS One, 11, pp.e0164189~ (2016)
- Dong, Y. L., "CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-kappaB activation via EGFR-transactivated Akt signaling", PLoS One, 8, pp.e83789~ (2013)
- Dobrzycka, B., "Circulating levels of TNF-alpha and its soluble receptors in the plasma of patients with epithelial ovarian cancer", Eur. Cytokine Netw, 20, pp.131~134 (2009)
- Maccio, A., "Inflammation and ovarian cancer", Cytokine, 58, pp.133~147 (2012)
- Szlosarek, P. W., "Expression and regulation of tumor necrosis factor alpha in normal and malignant ovarian epithelium", Mol. Cancer Ther, 5, pp.382~390 (2006)
- Urieli-Shoval, S., "Expression and function of serum amyloid A, a major acutephase protein, in normal and disease states", Curr. Opin. Hematol, 7, pp.64~69 (2000)
- Targonska-Stepniak, B., "Serum amyloid A as a marker of persistent inflammation and an indicator of cardiovascular and renal involvement in patients with rheumatoid arthritis", Mediators Inflamm, 2014, pp.793628~ (2014)
- Thorn, C. F., "Regulation of the human acute phase serum amyloid A genes by tumour necrosis factor-alpha, interleukin-6 and glucocorticoids in hepatic and epithelial cell lines", Scand. J. Immunol, 59, pp.152~158 (2004)
- Urieli-Shoval, S., "Expression of serum amyloid a in human ovarian epithelial tumors: implication for a role in ovarian tumorigenesis", J. Histochem. Cytochem, 58, pp.1015~1023 (2010)
- Kilkenny, C., "Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research", PLoS Biol, 8, pp.e1000412~ (2010)
- Son, D. S., "Interleukin-1alpha-induced chemokines in mouse granulosa cells: impact on keratinocyte chemoattractant chemokine, a CXC subfamily", Mol. Endocrinol, 20, pp.2999~3013 (2006)
- Son, D. S., "Interaction of adenosine 3', 5'-cyclic monophosphate and tumor necrosis factor-alpha on serum amyloid A3 expression in mouse granulosa cells : dependence on CCAAT-enhancing binding protein-beta isoform", Endocrinology, 151, pp.3407~3419 (2010)
- Perez-Llamas, "Gitools: analysis and visualisation of genomic data using interactive heat-maps", PLoS One, 6, pp.e19541~ (2011)
- Son, D. S., "Tumor necrosis factor-alpha induces serum amyloid A3 in mouse granulosa cells", Endocrinology, 145, pp.2245~2252 (2004)
- Hoesel, B., "The complexity of NFkappaB signaling in inflammation and cancer", Mol. Cancer, 12, pp.86~ (2013)